Cabotegravir-d3-1
Cabotegravir d3-1 (GSK-1265744-d3-1) is a deuterium substitute of Cabotegravir. Cabotegravir is a potent HIV integrase inhibitor used in AIDS research[1]
Product Specifications
Product Name Alternative
GSK-1265744-d3-1; S/GSK1265744-d3-1
UNSPSC
12352005
Target
HIV Integrase; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Metabolic Enzyme/Protease; Others
Applications
COVID-19-anti-virus
Field of Research
Infection
Solubility
10 mM in DMSO
Smiles
O=C1N2[C@H](CO[C@]2([H])CN3C1=C(C(C(C(NC([2H])([2H])C4=C(F)C([2H])=C(F)C=C4)=O)=C3)=O)O)C
Molecular Formula
C19H14D3F2N3O5
Molecular Weight
408.37
References & Citations
[1]Reese MJ, et al. Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from in vitro studies and a clinical investigation with midazolam. Xenobiotica. 2016;46 (5) :445-56.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
